Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$661K Sell
1,880
-1
-0.1% -$356 0.13% 109
2025
Q4
$616K Sell
1,881
-45
-2% -$14.3K 0.09% 137
2025
Q3
$544K Sell
1,926
-20
-1% -$5.8K 0.08% 152
2025
Q2
$543K Buy
1,946
+1
+0.1% +$283 0.09% 146
2025
Q1
$606K Sell
1,945
-18
-0.9% -$5.32K 0.11% 128
2024
Q4
$509K Sell
1,963
-46
-2% -$13.6K 0.09% 158
2024
Q3
$647K Buy
2,009
+5
+0.2% +$1.64K 0.11% 130
2024
Q2
$626K Sell
2,004
-3
-0.1% -$881 0.11% 125
2024
Q1
$571K Sell
2,007
-6
-0.3% -$1.76K 0.11% 142
2023
Q4
$580K Buy
2,013
+59
+3% +$16.1K 0.12% 124
2023
Q3
$525K Sell
1,954
-772
-28% -$193K 0.12% 130
2023
Q2
$605K Sell
2,726
-25
-0.9% -$5.8K 0.14% 119
2023
Q1
$665K Buy
2,751
+65
+2% +$16K 0.16% 108
2022
Q4
$703K Buy
2,686
+8
+0.3% +$2.14K 0.25% 104
2022
Q3
$604K Buy
2,678
+11
+0.4% +$2.67K 0.24% 110
2022
Q2
$659K Buy
2,667
+2
+0.1% +$490 0.22% 117
2022
Q1
$644K Buy
2,665
+1
+0% +$230 0.19% 134
2021
Q4
$599K Buy
2,664
+11
+0.4% +$2.32K 0.18% 142
2021
Q3
$570K Sell
2,653
-55
-2% -$12.7K 0.17% 150
2021
Q2
$649K Sell
2,708
-127
-4% -$31.2K 0.2% 128
2021
Q1
$679K Sell
2,835
-196
-6% -$46.8K 0.21% 124
2020
Q4
$697K Buy
+3,031
New +$699K 0.26% 101

Other funds holding AMGN

Insight Advisors's AMGN Position: Q1 2026 in Review

Insight Advisors reduced its Amgen (AMGN) stake by 0.05% in Q1 2026, selling an estimated $356 and leaving 1,880 shares worth $661K. The position accounts for 0.13% of the portfolio, ranked #109.

Insight Advisors first reported a position in AMGN in Q4 2020 and has held it in 22 quarters since. The position peaked at $703K in Q4 2022. 3,126 funds tracked by Wall St. Rank hold AMGN as of Q1 2026.

  • Insight Advisors held 1,880 shares of Amgen worth $661K as of Q1 2026.
  • Insight Advisors sold 1 Amgen share in Q1 2026, an estimated $356.
  • Amgen made up 0.13% of Insight Advisors's portfolio in Q1 2026, its #109 holding.
  • Insight Advisors first reported a position in Amgen in Q4 2020 and has held it in 22 quarters since.
  • Insight Advisors's Amgen position peaked at $703K in Q4 2022.
  • 3,126 funds tracked by Wall St. Rank held Amgen as of Q1 2026.

Based on Insight Advisors's 13F filing for Q1 2026, filed 12 May 2026.